Project 6: as (dietary) supplement to an approved drug product it is a change in formulation but no new approval from authorities seems necessary
Working title: “ARTECTION COMP”
Therapeutic Area: CV
Application Form: Tablet, coated Tablet, Capsule
Route of Administration: Oral
Probability of Realization: medium to high
Daily 8-PN dose (mg): 0.1 – 0.2 mg 8-PN/d plus 100mg ASS
Scientific Basis: see Project 5
Time to Market (best guess): 2 years